Women with lobular tumours were more significantly likely to be diagnosed with HR+/HER2- when compared to the other subtypes, in particular the TN (OR = 0.24; CI95% = [0.13–0.46]) and HER2-Overexpressing tumours (OR = 0.12; CI95% = [0.04–0.38]). Here, ERBB2 is linked to neoplasm.